Ir al menú principal
Ir al contenido principal
Ir al pie de página
Para
Medicare
Para
Proveedores
Para
Agentes
Para
Empleadores
English
Para individuos y familias:
Para individuos y familias
Médica
Dental
Otros seguros complementarios
Explorar cobertura a través de tu empleador
Cómo comprar seguros de salud
Tipos de seguro dental
Período de Inscripción Abierta vs. Período Especial de Inscripción
Ver todos los temas
Comprar planes de Medicare
Guía para miembros
Buscar un médico
Ingresar a myCigna
Inicio
Centro de información
Biblioteca del bienestar
Parkinson's Disease: Movement Problems From Levodopa
Parkinson's Disease: Movement Problems From Levodopa
Overview
Movement problems
Movement problems are common from long-term levodopa use. Most people who take levodopa develop some of these problems within 5 to 10 years. The main types of levodopa-related movement problems include motor (movement) fluctuations and dyskinesias.
- Motor fluctuations .
-
These are changes in the ability to move throughout the day. They may be called "on" and "off" times. When the medicine is working and movement is easy, it is "on." When it's harder to move and symptoms cause more problems, it is "off."
Wearing off happens when the effects of a dose of levodopa don't last as long as they used to. Symptoms come back before the next dose of levodopa. These changes can be predicted based on the timing of each dose.
"On" and "off" periods can also occur without warning. They can be hard to predict. An "off" period can occur suddenly, over seconds or minutes, and the person may freeze. Sometimes, long muscle spasms cause movement that can't be controlled. This can happen during on or off times.
- Dyskinesias.
-
Dyskinesias are sudden, random, uncontrollable, often jerky or twisting movements caused by the medicine. They may affect the head, neck, arms, and legs or other parts of the body.
Changing the dosage or when it is taken may help movement problems. Or other medicines may be added to help with these movement problems. Examples are amantadine, dopamine agonists, COMT inhibitors, MAO-B inhibitors, and apomorphine.
Current as of: December 20, 2023
Author: Ignite Healthwise, LLC Staff
Clinical Review Board
All Healthwise education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.
This information does not replace the advice of a doctor. Ignite Healthwise, LLC, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content.
To learn more about Ignite Healthwise, LLC, visit webmdignite.com.
© 2024-2025 Ignite Healthwise, LLC.
Enlaces relacionados
Parkinson's Disease
<cipublic-spinner variant="large"><span>Loading…</span></cipublic-spinner>